4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-001044
Chief Executive Officer sold 35,156 shares at $20.55 ($722,403)
- Chief Executive Officer acquired 35,156 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Morrison Briggs · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-08 | Exercise or conversion : show line 1 in the form | +35,156 | $7.20 | $253,123 | 83,492 | D |
| 2021-02-08 | Sale : show line 2 in the form | −35,156 | $20.55 | $722,403 | 48,336 | D |
| Open-market sales · 35,156 sh · avg $20.55 · $722,403 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-08 | Exercise or conversion : show line 3 in the form Stock Options (Right to buy) | −35,156 | 0 | D |
Loading xslF345X03/primarydocument.xml…